Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Hypoglycemia risk is generally low with GLP-1 agonists when used as monotherapy, as their glucose-lowering effect is glucose-dependent
By route of administration, the oral segment is expected to be the fastest-growing in the studied years
Engage in at least 150 minutes of moderate exercise per week, such as brisk walking or cycling
8-13 For a detailed discussion of cardiovascular outcome trials (CVOTs) completed with agents from the GLP-1 RA class, please refer to the companion lesson titled: What do we Currently Know about the Cardiovascular Benefits of GLP-1 RAs
In adult clinical trials, 9.8% of patients treated with SAXENDA and 4.3% of patients treated with placebo prematurely discontinued treatment as a result of adverse reactions
US$ 28.36
US$ 26.74
US$ 23.21
US$ 26.23
US$ 22.04
US$ 29.27
US$ 24.39
